Cancer In The News
The growing global cost of obesity was in the news this week, along with genetic tests for breast cancer and a rare childhood cancer.
New research suggests injury to the cells that line blood vessels could be behind severe side effects that some patients have after CAR T cell therapy.
This week’s news featured worrying obesity and cancer trends in the US and a call for more robust evidence to back up cancer drugs’ effectiveness. Read the digest for more...
Some cancer drugs approved in Europe might not have sufficient evidence of survival benefits, says study
New research has found that many cancer drugs recently approved in Europe lacked evidence from clinical trials that they boosted survival or quality of life.
From this week’s cancer news we look at how HIV research could offer clues about lung cancer and bust headlines about a radiotherapy ‘cure’ for prostate cancer.
Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.
In this week's news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.
A new recommendation by NICE gives certain lung cancer patients access to the immunotherapy drug nivolumab, through the Cancer Drugs Fund.
Professor Jack Cuzick has received our Lifetime Achievement Award for his work on cancer prevention and detection.
From this week’s cancer news we look at chemo-killing bacteria and ask: Can tattoos really give you cancer? Read the digest for more.